Meta-analysis for Tongxinluo capsules in the treatment of acute cerebral infarction
LU Jun-zhang
ZHANG Lei
CAO Xiu-tang
Abstract：Objective: To assess the effectiveness of Tongxinluo capsules in the treatment of acute cerebral infarction by Meta-analysis. Methods:The clinical studies of Tongxinluo capsules in treating acute cerebral infarction were collected and selected according to the criteria. Randomized controlled trials with the control group using basic treatment, while the treatment group using basic treatment combined with Tongxinluo capsules were included in this Meta-analysis. Results: A total of 13 RCTs were included. Tongxinluo treatment group showed better effectiveness than the control group. Adverse drug reactions and other harmful consequences weren't reported. The combined risk ratio (RR) was 1.26, 95%CI was [1.20, 1.33]. Conclusion:Our results showed Tongxinluo group was superior to control group in treating acute cerebral infarction. However, existence of some data methodological defects maybe directly affect the authenticity of the results. High quality, large samples and multiple center randomized controlled trials were needed to conifrm the efifcacy and safety.
Keywords：Acute cerebral infarctionTongxinluo capsulesMeta-analysis
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 201-203,223 )